Evidence map›Paper›PMID 40166822›Full record

ReviewAdvanced healthcare materials2025

Engineering the Future of Restorative Clinical Peripheral Nerve Surgery.

Justin C Burrell, Zarina S Ali, Eric L Zager, Joseph M Rosen, Mykhailo M Tatarchuk, D Kacy Cullen

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Engineering Silk Fibroin-Based Biomaterials for Neural Repair.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justin C BurrellCenter for Brain Injury & Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID https://orcid.org/0000-0002-5361-9224
Zarina S AliCenter for Brain Injury & Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Eric L ZagerCenter for Brain Injury & Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Joseph M RosenDivision of Plastic Surgery, Dartmouth-Hitchcock Medical Center, Dartmouth College, Lebanon, NH, 03766, USA.
Mykhailo M TatarchukCenter for Brain Injury & Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID https://orcid.org/0000-0002-2297-2527
D Kacy CullenCenter for Brain Injury & Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.ORCID https://orcid.org/0000-0002-5355-5216

Funding

NRSA Training CoreTL1TR001880 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$10.0M
Tissue Engineered Rostral Migratory Stream for Directed Neuronal ReplacementR01NS117757 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI CULLEN, DANIEL KACY · 2021 to 2025
$2.9M
Development of Tissue Engineered Neuromuscular Interfaces from GalSafe NeuronsR44NS125892 · NINDS · AXONOVA MEDICAL, LLC · PI Kritika Katiyar · 2024 to 2026
$2.8M
Tissue Engineered Motor Units for Neuromuscular Modeling and RepairR01AR083489 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Daniel Kacy Cullen · 2024 to 2026
$1.7M
Advanced Training at the Interface of Engineering and Oral-Craniofacial SciencesT90DE030854 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI Hyun Koo, Kathleen J Stebe · 2021 to 2026
$1.4M
Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons.R43NS125892 · NINDS · AXONOVA MEDICAL, LLC · PI KATIYAR, KRITIKA · 2022 to 2022
$250k
NCATS NIH HHS TL1 TR001880NIAMS NIH HHS R01 AR083489NIAMS NIH HHS R01-AR083489NIDCR NIH HHS T90 DE030854NIDCR NIH HHS T90-DE030854NIGMS NIH HHS TL1-TR001880NINDS NIH HHS R01 NS117757NINDS NIH HHS R01-NS117757NINDS NIH HHS R43 NS125892NINDS NIH HHS R44 NS125892RRD VA I01 RX005045U.S. Department of Defense OR230229U.S. Department of Veterans Affairs I01-RX005045
6 · The paper itself

Abstract

Peripheral nerve injury is a significant clinical challenge, often leading to permanent functional deficits. Standard interventions, such as autologous nerve grafts or distal nerve transfers, require sacrificing healthy nerve tissue and typically result in limited motor or sensory recovery. Nerve regeneration is complex and influenced by several factors: 1) the regenerative capacity of proximal neurons, 2) the ability of axons and support cells to bridge the injury, 3) the capacity of Schwann cells to maintain a supportive environment, and 4) the readiness of target muscles or sensory organs for reinnervation. Emerging bioengineering solutions, including biomaterials, drug delivery systems, fusogens, electrical stimulation devices, and tissue-engineered products, aim to address these challenges. Effective translation of these therapies requires a deep understanding of the physiology and pathology of nerve injury. This article proposes a comprehensive framework for developing restorative strategies that address all four major physiological responses in nerve repair. By implementing this framework, we envision a paradigm shift that could potentially enable full functional recovery for patients, where current approaches offer minimal hope.

Indexed as

Nerve RegenerationPeripheral Nerve InjuriesPeripheral NervesTissue EngineeringAnimalsBiocompatible MaterialsHumansSchwann CellsBiocompatible Materialsbioengineered tissuenerve injurynerve regenerationneurological injurytissue engineering

Identifiers

PMID40166822
PMCPMC12333482

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.